EGR1 overexpression is well correlated with the loss of its co-repressor NAB2 in primary prostate carcinoma; this unbalance between EGR1 and NAB2 expression results in high EGR1 transcriptional activity in prostate carcinoma cells [29]. This evidence concerns the gene EGR1 and prostate carcinoma.